Cargando…

AR Signaling and the PI3K Pathway in Prostate Cancer

Prostate cancer is a leading cause of cancer-related death in men worldwide. Aberrant signaling in the androgen pathway is critical in the development and progression of prostate cancer. Despite ongoing reliance on androgen receptor (AR) signaling in castrate resistant disease, in addition to the de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crumbaker, Megan, Khoja, Leila, Joshua, Anthony M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406709/ https://www.ncbi.nlm.nih.gov/pubmed/28420128 http://dx.doi.org/10.3390/cancers9040034

Ejemplares similares

The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
por: Shorning, Boris Y., et al.
Publicado: (2020)

Combination effect of therapies targeting the PI3K- and AR-signaling pathways in prostate cancer
por: Yadav, Shalini Singh, et al.
Publicado: (2016)

AR and PI3K/AKT in Prostate Cancer: A Tale of Two Interconnected Pathways
por: Tortorella, Elisabetta, et al.
Publicado: (2023)

Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
por: Raith, Fabio, et al.
Publicado: (2023)

Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer
por: de Nóbrega, Monyse, et al.
Publicado: (2020)

AR-Signaling in Human Malignancies: Prostate Cancer and Beyond
por: Schweizer, Michael T., et al.
Publicado: (2017)

The Role of Polymorphisms in Genes of PI3K/Akt Signaling Pathway on Prostate
por: Xu, Wei, et al.
Publicado: (2019)

The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases
por: Iranpanah, Amin, et al.
Publicado: (2023)

Androgen Plays a Carcinogenic Role in EOC via the PI3K/AKT Signaling Pathway in an AR-Dependent Manner
por: Li, Yanfang, et al.
Publicado: (2021)

Research progress on the PI3K/AKT signaling pathway in gynecological cancer
por: Shi, Xiang, et al.
Publicado: (2019)

PI3K at the crossroads of tumor angiogenesis signaling pathways
por: Soler, Adriana, et al.
Publicado: (2015)

The effects of Ginsenosides on PI3K/AKT signaling pathway
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
por: Roudsari, Nazanin Momeni, et al.
Publicado: (2021)

Emerging proteins involved in castration-resistant prostate cancer via the AR-dependent and AR-independent pathways (Review)
por: Feng, Kangle, et al.
Publicado: (2023)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization
por: Tóthová, Zuzana, et al.
Publicado: (2021)

Non-nuclear AR Signaling in Prostate Cancer
por: Zamagni, Alice, et al.
Publicado: (2019)

AR, the cell cycle, and prostate cancer
por: Balk, Steven P., et al.
Publicado: (2008)

ACK1–AR and AR–HOXB13 signaling axes: epigenetic regulation of lethal prostate cancers
por: Kim, Eric H, et al.
Publicado: (2020)

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
por: Li, Huayi, et al.
Publicado: (2021)

Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment
por: Makino, Tomoyuki, et al.
Publicado: (2021)

Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer
por: Pungsrinont, Thanakorn, et al.
Publicado: (2021)

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
por: Glaviano, Antonino, et al.
Publicado: (2023)

CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway
por: Li, Linjin, et al.
Publicado: (2022)

SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer
por: Xiao, Zhao-Ming, et al.
Publicado: (2021)

LTBP2 inhibits prostate cancer progression and metastasis via the PI3K/AKT signaling pathway
por: Zhang, Xiaowen, et al.
Publicado: (2022)

AR Signaling in Breast Cancer
por: Rahim, Bilal, et al.
Publicado: (2017)

Clinical values of expression signature of circCDR1AS and circHIAT1 in prostate cancer: Two circRNAs with regulatory function in androgen receptor (AR) and PI3K/AKT signaling pathways
por: Aghajani Mir, Mahsa, et al.
Publicado: (2022)

PI3K/Akt and HIF-1 signaling pathway in hypoxia-ischemia
por: Zhang, Zhen, et al.
Publicado: (2018)

PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia
por: Xie, Youbang, et al.
Publicado: (2019)

AR Signaling in Human Malignancies: Prostate Cancer and Beyond
por: Antonarakis, Emmanuel S.
Publicado: (2018)

Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer
por: Jaiswal, Bharti, et al.
Publicado: (2022)

The Biological Role of PI3K Pathway in Lung Cancer
por: Sarris, Evangelos G., et al.
Publicado: (2012)

The Role of the PI3K Signaling Pathway in CD4(+) T Cell Differentiation and Function
por: Han, Jonathan M., et al.
Publicado: (2012)

PI3K-AKT-mTOR Pathway is Dominant over Androgen Receptor Signaling in Prostate Cancer Cells
por: Kaarbø, Mari, et al.
Publicado: (2010)

Coordinated AR and microRNA regulation in prostate cancer
por: Eringyte, Ieva, et al.
Publicado: (2020)

Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
por: Xue, Chen, et al.
Publicado: (2021)

Treating non-small cell lung cancer by targeting the PI3K signaling pathway
por: Jiang, Lin, et al.
Publicado: (2022)

Somatic Alterations Impact AR Transcriptional Activity and Efficacy of AR-Targeting Therapies in Prostate Cancer
por: Chauhan, Gaurav, et al.
Publicado: (2021)

Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer
por: Liu, Jie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8p6sst1v2k189forq30k8legl9